Title: Public Health Reporting and National Notification for Shigellosis

Similar documents
09-ID-67. Committee: Infectious. Title: Public Health Reporting and National Notification for Typhoid Fever. I. Statement of the Problem

09-ID-04. Committee: Infectious. Title: Public Health Reporting and National Notification for Cyclosporiasis. I. Statement of the Problem

I. Statement of the Problem: The case definition of giardiasis, a disease under public health surveillance, is in need of a revision.

Title: Public Health Reporting and National Notification for Escherichia coli, Shiga toxinproducing

Title: National Surveillance for Paralytic Poliomyelitis and Nonparalytic Poliovirus Infection

In the setting of measles elimination in the United States, the current measles case definition lacks specificity.

Title: Public Health Reporting and National Notification for Trichinellosis

Title: Expanding Wound Botulism Surveillance Case Definitions

11-ID-14. Committee: Infectious Disease. Title: Update to Cryptosporidiosis Case Definition

Title: Public Health Reporting and National Notification for Coccidioidomycosis

Update to Public Health Reporting and National Notification for Hansen s disease

Page 1 of 9 13-ID ID-08. Public Health Reporting and National Notification for Malaria

Title: Revision to the Standardized Surveillance and Case Definition for Acute Flaccid Myelitis

17-ID-09. Title: Establishing a Case Definition for Latent TB Infection (TB Infection)

Title: Public Health Reporting and National Notification for Gonorrhea

Title: Public Health Reporting and National Notification for streptococcal toxic shock syndrome (STSS)

Title: Enhancing state-based surveillance for invasive pneumococcal disease

Position Statement Template

14-ID-06. Revision of the National Surveillance Case Definition for Meningococcal Disease

Title: National Surveillance for Severe Acute Respiratory Syndrome (SARS-CoV)

Title: Public Health Reporting and National Notification for Lyme Disease

Title: Standardized Surveillance for Campylobacteriosis and Addition to the Nationally Notifiable Condition List

Check this box if this position statement is an update to an existing standardized surveillance case definition.

Title: Public Health Reporting and National Notification for Shiga Toxin-Producing Escherichia coli (STEC)

Title: Public Health Ascertainment and National Notification for Silicosis

Check this box if this position statement is an update to an existing standardized surveillance case definition.

Revision of the pertussis surveillance case definition to more accurately capture the burden of disease among infants <1 year of age

Check this box if this position statement is an update to an existing standardized surveillance case definition.

3. Rapidly recognize influenza seasons in which the impact of influenza appears to be unusually severe among children.

Performance Indicators for Foodborne Disease Programs

Position Statement Template

5/4/2018. Describe the public health surveillance system for communicable diseases.

Title: Public Health Reporting and National Notification for Elevated Blood Lead Levels

Title: Public Health Reporting and National Notification for Elevated Blood Lead Levels

with a state park - New Jersey 2012 Rebecca Greeley, MPH Antimicrobial Resistance & Waterborne Disease Coordinator, NJDOH

Department of Epidemiological Surveillance and Intervention

Yersiniosis rev Apr 2017

Infectious Diseases - Foodborne, Tennessee Department of Health, Communicable and Environmental Disease Services Assignment Description

What to do with Sick Food Handlers? Michelle Malavet, MSA, HO, REHS Foodborne Disease Surveillance Coordinator NJDOH, Communicable Disease Service

Surveillance and outbreak response are major components

WHO Surveillance Programme for Control of Foodborne Infections and Intoxications in Europe 8th Report Country Reports: Armenia ARMENIA

11-SI-02. Committee: Surveillance Informatics Steering Committee

Enteric Illness. Shigellosis

Cholera Table of Contents

Shiga Toxin Producing. Escherichia Coli (STEC)

Giardiasis Surveillance Protocol

Update on infections with and clinical lab guidelines for Shiga toxin-producing E. coli (STEC) in the United States

Position Statement Template

Council for Outbreak Response: Healthcare-Associated Infections & Antibiotic-Resistant Pathogens (CORHA) HICPAC December 1, 2016

Council of State and Territorial Epidemiologists Position Statement

Re: Shigellosis (Bacillary Dysentery) Reporting and Case Investigation

Management and Reporting of Vaccine Preventable Diseases in Schools. Shirley A. Morales,MPH,CIC

Streptococcus Pneumoniae

Communicable Disease Control And Health Protection Handbook Third Edition

Vibrio surveillance in the CIDT Era

14-ID-07. Standardized Surveillance Case Definition for Cryptococcus gattii infection

Influenza Surveillance in the United St ates

Trichinosis Table of Contents

Legionellosis Surveillance System Evaluation

CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES

Positive for carbapenemase production by a phenotypic method

Department of Epidemiological Surveillance and Intervention

New Jersey Department of Health Communicable Disease Service OUTBREAK REPORT FOR LONG TERM CARE AND OTHER INSTITUTIONS

Laboratory diagnosis Surveillance and outbreak detection Outbreak investigation

WYANDOT COUNTY 2016 COMMUNICABLE DISEASE REPORT

Appendix B: Provincial Case Definitions for Diseases of Public Health Significance

16-ID ID-01 Revised 7/29/16 1

E. coli O157:H7 Outbreak Associated with Consumption of Unpasteurized Milk, Kentucky, 2014

SHIGA TOXIN-PRODUCING SHIGELLA SONNEI IN SOUTHERN CALIFORNIA, 2014

Influenza : What is going on? How can Community Health Centers help their patients?

Giardiasis. Table of Contents

Title: Public Health Reporting and National Surveillance for Babesiosis

Ascariasis rev Jan 2018

Amebiasis rev Jan 2018

What you need to know... Notifiable Diseases/Conditions. Alabama Department of Public Health (ADPH) Bureau of Communicable Disease - Epidemiology

Nashville, Tennessee. Assignment Description

WYANDOT COUNTY 2016 COMMUNICABLE DISEASE REPORT

Appendix A: Disease-Specific Chapters

Hepatitis A Surveillance Protocol

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

Bacterial Enteric Infections Detected by Culture-Independent Diagnostic Tests FoodNet, United States,

Influenza-Associated Pediatric Mortality rev Jan 2018

Message Mapping Guide (MMG) Development Update: Status of Work, Lessons Learned, and Enhancements

Vibrio Cholerae (non-o1, non-o139)

Group B Streptococcus

Disparities of Shigellosis Rates Among California Children by Census Tract Poverty Level and by Race/Ethnicity,

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August 2011

(and what you can do about them)

EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS IN IRELAND

Norovirus Outbreak in a Children s Hospital. Jennifer Adams, MT, MPH, CIC April 23, 2015

Appendix A: Disease-Specific Chapters

When a Cluster Becomes an Outbreak The Multistate Perspective

Polio (Paralytic and Non-paralytic

EPIDEMIOLOGY OF HEPATITIS A IN IRELAND

Prevention and Control of Healthcare-Associated Norovirus

UNION COUNTY 2017 COMMUNICABLE DISEASE REPORT

Mahoning County Public Health. Epidemiology Response Annex

Reportable Communicable Disease Investigation in New Jersey

Appendix B: Provincial Case Definitions for Reportable Diseases

Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years

Transcription:

11-ID-19 Committee: Infectious Title: Public Health Reporting and National Notification for Shigellosis I. Statement of the Problem Currently, case confirmation for Shigellosis is dependent on isolation of Shigella from a clinical specimen using culture-based methods. However, there has been an increase in the use of nonculture based methods to clinically diagnosis Shigellosis. According to the 2010 case definition for Shigellosis, if Shigella is diagnosed by non-culture methods it is classified as Not a Case. At least one laboratory specializing in non-culture based methods for testing infectious agents is being used by physicians in several states for the diagnosis of enteric infections, even though the positive predictive value for these methods are unknown. This particular method can be performed on a stool swab, which is not suitable for further characterization (i.e., serotype and PFGE) if not immediately added to an appropriate preservative. The increasing use of non-culture based diagnostic methods is concerning for a couple of reasons. ne, infections diagnosed in this manner do not meet the current laboratory criteria for case classification. Additionally, national-level efforts to monitor pathogenic enteric infections in order to identify and respond to multi-state outbreaks will be handicapped. A change to the case classification categories for Shigellosis is needed to prevent an increase in underreporting of Shigellosis cases. II. Background and Justification Background Shigellosis is characterized by diarrhea with fever, bloody stools, and mucus in the stools, cramps, abdominal pain, tenesmus and nausea. Asymptomatic cases are possible. Food- and waterborne outbreaks may occur. utbreaks in daycare centers are common. International travelers are at risk of contracting Shigellosis. Justification ngoing surveillance of Shigella infections is needed to detect and control outbreaks as well as evaluate strategies to prevent Shigella infections. III. Statement of the desired action(s) to be taken Page 1 of 8

CSTE requests that CDC adopt this new case definition category for Shigellosis in order to accommodate cases diagnosed by non-culture based methods. By adding a Suspect category, Public Health will be able to track and assess Shigella cases diagnosed by non-culture based methods. IV. Goals of Surveillance To provide information on the temporal, geographic, and demographic occurrence of Shigellosis to facilitate its prevention and control. V. Methods for Surveillance Surveillance for Shigellosis should use the sources of data and the extent of coverage listed in Table V below. Table V. Recommended sources of data and extent of coverage for ascertaining cases of Shigellosis. Coverage Source of data for case ascertainment Population-wide Sentinel sites clinician reporting laboratory reporting reporting by other entities (e.g., hospitals, veterinarians, pharmacies) death certificates hospital discharge or outpatient records extracts from electronic medical records telephone survey school-based survey other VI. Criteria for Reporting Reporting refers to the process of healthcare providers or institutions (e.g., clinicians, clinical laboratories, hospitals) submitting basic information to governmental public health agencies about cases of illness that meet certain reporting requirements or criteria. The purpose of this section is to provide those criteria to determine whether a specific illness should be reported. A. Narrative description of criteria to determine whether a case should be reported to public health authorities Page 2 of 8

Report any illness to public health authorities that meets any of the following criteria: 1. Any person with Shigella sp. isolated from a clinical specimen. 2. Any person with Shigella sp. detected using non-culture based methods. 3. A person with diarrhea who is a contact of a person with confirmed Shigella infection or is a member of a risk group defined by public health authorities during an outbreak. ther recommended reporting procedures All cases of Shigellosis should be reported. Reporting should be on-going and routine. Frequency of reporting should follow the state health department s routine schedule. B. Table of criteria to determine whether a case should be reported to public health authorities Table VI-B. Table of criteria to determine whether a case should be reported to public health authorities. Requirements for reporting are established under State and Territorial laws and/or regulations and may differ from jurisdiction to jurisdiction. These criteria are suggested as a standard approach to identifying cases of this condition for purposes of reporting, but reporting should follow State and Territorial law/regulation if any conflicts occur between these criteria and those laws/regulations. Criterion Clinical Evidence Diarrhea Laboratory Evidence Isolation of Shigella sp from a clinical specimen Detection of Shigella sp from a clinical specimen using a non-culture based method Epidemiologic Evidence Contact of a confirmed case of Shigellosis S S Reporting Member of a risk group defined by the public health authorities during an outbreak Notes: S = This criterion alone is Sufficient to identify a case for reporting. N = All N criteria in the same column are Necessary to identify a case for reporting. = At least one of these (ptional) criteria in each category (i.e., clinical evidence and laboratory evidence) in the same column in conjunction with all N criteria in the same column is required to identify a case for reporting. C. Disease Specific Data Elements: Disease-specific data elements to be included in the initial report are listed below. N Page 3 of 8

Epidemiological Risk Factors Food handler Day care center attendee Household contact of a day care center attendee Day care center worker MSM Contact with recreational water International travel in the 7 days prior to onset Countries visited Clinical Data Treatment with antimicrobial agents Name of medication Date treatment began Date treatment ended Hospitalized Duration of diarrhea in days VII. Case Definition A. Narrative description of criteria to determine whether a case should be classified as confirmed, probable, or suspect. Clinical description An illness of variable severity characterized by diarrhea, fever, nausea, cramps, and tenesmus. Asymptomatic infections may occur. Laboratory criteria for diagnosis Suspect: Detection of Shigella from a clinical specimen using a non-culture based method Confirmed: Isolation of Shigella from a clinical specimen Case classification Suspect: a case that meets the suspect laboratory criteria for diagnosis Probable: a clinically compatible case that is epidemiologically linked, i.e., is a contact of a confirmed case or a member of a risk group defined by public health authorities during an outbreak. Page 4 of 8

Confirmed: a case that meets the confirmed laboratory criteria for diagnosis. When available, species characterization should be reported. Comment Both asymptomatic infections and infections at sites other than the gastrointestinal tract, if laboratory confirmed, are considered confirmed cases that should be reported. B. Classification Tables Table VII-B lists the criteria that must be met for a case to be classified as confirmed, probable, or suspect. Table VII-B. Table of criteria to determine whether a case is classified. Criterion Clinical Evidence Diarrhea Fever Bloody stools Mucus in stools Nausea Abdominal cramps Tenesmus Laboratory Evidence Isolation of Shigella from a clinical specimen Detection of Shigella from a clinical specimen using a non-culture based method Epidemiologic Evidence Contact of a confirmed case of Shigellosis Case Definition Confirmed Probable Suspect Member of a risk group defined by the public health authorities during an outbreak Notes: S = This criterion alone is Sufficient to classify a case. N = All N criteria in the same column are Necessary to classify a case. = At least one of these (ptional) criteria in each category (i.e., clinical evidence and laboratory evidence) in the same column in conjunction with all N criteria in the same column is required to classify a case. S N N Page 5 of 8

VIII. Period of Surveillance Surveillance should be on-going. I. Data sharing/release and print criteria Notification to CDC for confirmed and probable cases of Shigellosis is recommended. Data will be used to determine the burden of illness due to Shigella, assess the effectiveness over time of control programs, and assess the progress toward Shigellosis control. Data may also be used to compare case numbers with information from other foodborne disease surveillance systems. Electronic reports of Shigellosis cases in NNDSS are also summarized weekly in the MMWR Tables. Annual case data on Shigellosis is summarized in the yearly Summary of Notifiable Diseases. State-specific compiled data will continue to be published in the weekly and annual MMWR. All cases are verified with the states before publication. The frequency of reports/feedback to the states and territories will be dependent on the current epidemiologic situation in the country. Frequency of cases, epidemiologic distribution, importation status transmission risk, and other factors will influence communications. Page 6 of 8

. References Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46(No. RR-10):1 57. Available from: http://www.cdc.gov/mmwr/ Centers for Disease Control and Prevention (CDC). National notifiable diseases surveillance system: case definitions. Atlanta: CDC. Available from: http://www.cdc.gov/osels/ph_surveillance/nndss/phs/infdis2011.htm Last updated: 2011 Feb. 10. Accessed: 15 June 2011. Council of State and Territorial Epidemiologists (CSTE). CSTE official list of nationally notifiable conditions. CSTE position statement 09-ID-57. Atlanta: CSTE; June 2009. Available from: http://www.cste.org. Heymann DL, editor. Control of communicable diseases manual. 18th edition. Washington: American Public Health Association; 2004. DuPont HL. Shigella Species (Bacillary Dysentery) In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases, 6th edition. Philadelphia: Churchill Livingstone; 2005. Page 7 of 8

I. Coordination: Agencies for Response: (1) Thomas R Frieden, MD, MPH Director Centers for Disease Control and Prevention 1600 Clifton Road, NE Atlanta GA 30333 (404) 639-7000 txf2@cdc.gov II. Submitting Author: (1) Sherri L. Davidson, MPH Analysis & Reporting Branch Manager Epidemiology Division Alabama Department of Public Health 201 Monroe Street, Suite 1452 Montgomery, AL 36104 334-206-2050 Sherri.Davidson@ADPH.state.AL.US Co-Authors: (1) Associate Member Ana L. liveira, DrPH, MSPH, MS Research Associate University of Alabama at Birmingham 510 20 th Street South, FT 805A Birmingham, AL 35294 205-975-2405 AnaLuna@uab.edu Page 8 of 8